This Article Full Text Full Text (PDF) All Versions of this Article: 30/1/41    most recent Author Manuscript (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Canto, P. Articles by Méndez, J. P. Search for Related Content PubMed PubMed Citation Articles by Canto, P. Articles by Méndez, J. P.

Genetic Analysis in Patients With Kallmann Syndrome: Coexistence of Mutations in Prokineticin Receptor 2 and KAL1

J. P. MÉNDEZ^*,

From the ^* Unidad de Investigación Médica en Biología del Desarrollo, Centro Médico Nacional Siglo XXI, Coordinación de Investigación en Salud, Instituto Mexicano del Seguro Social, México, D.F., México.

Correspondence to: Dr Juan Pablo Méndez, Research Unit in Developmental Biology, Coordinación de Investigación en Salud, Coahuila 5, Apartado Postal A-047, Colonia Roma, C.P. 06703, México, D.F., México (e-mail: jpmb{at}servidor.unam.mx).

Kallmann syndrome (KS) is characterized by the association of hypogonadotropic hypogonadism and anosmia or hyposmia. To date, 4 different genes have been identified as responsible for the presence of KS; however, in many cases no mutations have been found in any of these genes. Herein, we report the molecular findings regarding the analysis of fibroblast growth factor receptor 1 (FGFR1), prokineticin receptor 2 (PROKR2), and prokineticin (PROK2) in patients with KS. Twenty-four patients with KS were studied in whom mutations in KAL1 had been investigated previously. Polymerase chain reaction products from FGFR1, PROKR2, and PROK2 were sequenced and mutations were sought in the open reading frame of the 3 genes. Two patients presented a heterozygous T-to-G transversion in exon 2 (c.518T>G) of the PROKR2, which results in a leucine-to-arginine substitution at codon 173. Our results strengthen the hypothesis of possible digenic inheritance in some patients with KS. Likewise, our data extend previous reports demonstrating that PROKR2 plays a role in the etiology of this syndrome.

     Key words: Digenic inheritance, p.L173R

This article has been cited by other articles:

				C. Martin, R. Balasubramanian, A. A. Dwyer, M. G. Au, Y. Sidis, U. B. Kaiser, S. B. Seminara, N. Pitteloud, Q.-Y. Zhou, and W. F. Crowley Jr The Role of the Prokineticin 2 Pathway in Human Reproduction: Evidence from the Study of Human and Murine Gene Mutations Endocr. Rev., April 1, 2011; 32(2): 225 - 246. [Abstract] [Full Text] [PDF]

				G. P. Sykiotis, L. Plummer, V. A. Hughes, M. Au, S. Durrani, S. Nayak-Young, A. A. Dwyer, R. Quinton, J. E. Hall, J. F. Gusella, et al. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency PNAS, August 24, 2010; 107(34): 15140 - 15144. [Abstract] [Full Text] [PDF]

				E. C. Engle Human Genetic Disorders of Axon Guidance Cold Spring Harb Perspect Biol, March 1, 2010; 2(3): a001784 - a001784. [Abstract] [Full Text] [PDF]

				Y.-M. Chan, A. de Guillebon, M. Lang-Muritano, L. Plummer, F. Cerrato, S. Tsiaras, A. Gaspert, H. B. Lavoie, C.-H. Wu, W. F. Crowley Jr., et al. GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism PNAS, July 14, 2009; 106(28): 11703 - 11708. [Abstract] [Full Text] [PDF]